ASX:NSB ASX Announcement 22 October 2026 Appointment of CFO NeuroScientific Biopharmaceuticals Limited (ASX:NSB) (“NeuroScientific”, “NSB” or the “Company”), an innovative Australian biotechnology company developing novel technologies targeted at immune-mediated inflammatory diseases...
Appointment of CFO
Filed with ASX · · 2 pages · English
6ix is checking which company filed this.
Earlier from Miro Sciences
- Results of Annual General Meeting
- US FDA Provides Positive Feedback on Planned Phase 2 Trial
- Leading CRO Appointed for Phase 2 Crohn's Trial
- Notice of Annual General Meeting & Proxy Form
- Letter to Shareholders & Proxy Form
